Barrington Research Downgrades Lifecore Biomedical to Market Perform

Benzinga Newsdesk Sep 29, 2026 1 month ago

Analyst RatingsNewsDowngrades

Barrington Research analyst Michael Petusky downgrades Lifecore Biomedical (NASDAQ:LFCR) from Outperform to Market Perform.